Update on Syphilis: Resurgence of an Old Problem

JAMA

Volumn 290, Issue 11, 2003, Pages 1510-1514

  Golden, Matthew R ^a,b,c   Marra, Christina M ^a   Holmes, King K ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BENZATHINE PENICILLIN; CEFTRIAXONE; DOXYCYCLINE; PENICILLIN G; PROBENECID; PROCAINE PENICILLIN;

AGE DISTRIBUTION; ANTIBODY TITER; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CLINICAL PROTOCOL; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION CONTROL; INFECTION RATE; NEUROSYPHILIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; SERODIAGNOSIS; SEX DIFFERENCE; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; SYPHILIS; TREATMENT FAILURE; TREPONEMA PALLIDUM; VIRUS LATENCY; VIRUS SHEDDING; VIRUS TRANSMISSION; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ISOLATION AND PURIFICATION; SYPHILIS SEROLOGY; UNITED STATES;

DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; HIV INFECTIONS; HUMANS; NEUROSYPHILIS; SYPHILIS; SYPHILIS SERODIAGNOSIS; TREPONEMA PALLIDUM; UNITED STATES;

EID: 0141500166     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.11.1510     Document Type: Review

References (41)

1. Parran T. Shadow on the Land. New York, NY: Reynal & Hitchcock; 1937.
2. Centers for Disease Control and Prevention, National Center for HIV, STD and TB Prevention, Division of Sexually Transmitted Diseases. Sexually Transmitted Diseases Surveillance 2001. Atlanta, Ga: CDC; September, 2002.
3. Laumann EO, Youm Y. Racial/ethnic group differences in the prevalence of sexually transmitted diseases in the United States: a network explanation. Sex Transm Dis. 1999;26:250-261.
4. Ciesielski CA. Sexually transmitted diseases in men who have sex with men: an epidemiologic review. Curr Infect Dis Rep. 2003;5:145-152.
5. Katz MH, Schwarcz SK, Kellogg TA, et al. Impact of highly active antiretroviral treatment on HIV sero-incidence among men who have sex with men: San Francisco. Am J Public Health. 2002;92:388-394.
6. Primary and secondary syphilis among men who have sex with men-New York City, 2001. MMWR Morb Mortal Wkly Rep. 2002;51:853-856.
7. Blocker ME, Levine WC, St Louis ME. HIV prevalence in patients with syphilis, United States. Sex Transm Dis. 2000;27:53-59.
8. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3-17.
9. Clark G, Danbolr N. The Oslo study of the natural course of untreated syphilis: an epidemiologic investigation based on re-study of the Boeck-Bruusgaard material. Med Clin North Am. 1964;48:613-623.
10. Stokes J, Beerman H, Ingraham N. Modern Clinical Syphilology. 3rd ed. Philidelphia, Pa: WB Saunders Co; 1945.
11. Merritt H, Adarns R, Solomon H. Neurosypilis. New York, NY: Oxford University Press; 1940.
12. Garnett GP, Aral SO, Hoyle DV, Cates W Jr, Anderson RM. The natural history of syphilis: implications for the transmission dynamics and control of infection. Sex Transm Dis. 1997;24:185-200.
13. DiCarlo RP, Martin DH. The clinical diagnosis of genital ulcer disease in men. Clin Infect Dis. 1997;25: 292-298.
14. Rompalo AM, Joesoef MR, O'Donnell JA, et al. Clinical manifestations of early syphilis by HIV status and gender: results of the syphilis and HIV study. Sex Transm Dis. 2001;28:158-165.
15. Hutchinson CM, Hook EW 3rd, Shepherd M, Verley J, Rompalo AM. Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection. Ann Intern Med. 1994;121:94-100.
16. Rosahn P. Autopsy studies of syphilis. J Vener Dis. 1947;649(suppl 21):1-67.
17. Collis TK, Celum CL. The clinical manifestations and treatment of sexually transmitted diseases in human immunodeficiency virus-positive men. Clin Infect Dis. 2001;32:611-622.
18. Rolfs RT, Joesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection: the Syphilis and HIV Study Group. N Engl J Med. 1997;337:307-314.
19. Hart G. Syphilis tests in diagnostic and therapeutic decision making. Ann Intern Med. 1986;104:368-376.
20. Larsen S, Kraus S, Whittington W. Diagnostic tests. In: Larsen SA, Hunter E, Kraus S, eds. A Manual of Tests for Syphilis. Washington, DC: American Public Health Association; 1990:2-26.
21. Hicks CB, Benson PM, Lupton GP, Tramont EC. Seronegative secondary syphilis in a patient infected with the human immunodeficiency virus (HIV) with Kaposi sarcoma: a diagnostic dilemma. Ann Intern Med. 1987;107:492-495.
22. Erbelding EJ, Vlahov D, Nelson KE, et al. Syphilis serology in human immunodeficiency virus infection: evidence for false-negative fluorescent treponemal testing. J Infect Dis. 1997;176:1397-1400.
23. Romanowski B, Sutherland R, Fick GH, Mooney D, Love EJ. Serologic response to treatment of infectious syphilis. Ann Intern Med. 1991;114:1005-1009.
24. Lukehart SA, Hook EW 3rd, Baker-Zander SA, Collier AC, Critchlow CW, Handsfield HH. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med. 1988;109:855-862.
25. Fernando WL. Cerebrospinal fluid findings after treatment of early syphilis with penicillin: a further series of 80 cases. Br J Vener Dis. 1968;44:134-135.
26. Marra CM, Boutin P, McArthur JC, et al. A pilot study evaluating ceftriaxone and penicillin Gas treatment agents for neurosyphilis in human immunodeficiency virus-infected individuals. Clin Infect Dis. 2000; 30:540-544.
27. Sexually transmitted treatment guidelines 2002: Centers for Disease Control and Prevention. MMWR Recomm Rep. 2002;51(RR-6):1-78.
28. Marra C, Maxwell C, Smith S, et al. Risk factors for neurosyphilis. Paper presented at: 2002 National STD prevention conference, 2002; San Diego, Calif.
29. Marra CM, Critchlow CW, Hook EW 3rd, Collier AC, Lukehart SA. Cerebrospinal fluid treponemal antibodies in untreated early syphilis. Arch Neurol 1995; 52:68-72.
30. Schroeter AL, Lucas JB, Price EV, Falcone VH. Treatment for early syphilis and reactivity of serologic tests. JAMA. 1972;221:471-476.
31. Elliott WC. Treatment of primary syphilis. J Am Vener Dis Assoc. 1976;3(2 pt 2):128-135.
32. Brown ST. Treatment of secondary syphilis. J Am Vener Dis Assoc. 1976;3(2 pt 2):136-142.
33. Hook EW 3rd, Stephens J, Ennis DM. Azithromycin compared with penicillin G benzathine for treatment of incubating syphilis. Ann Intern Med. 1999; 131:434-437.
34. Hook EW 3rd, Martin DH, Stephens J, Smith BS, Smith K. A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis. 2002;29:486-490.
35. Riedner G, Dehne KL, Gromyko A. Recent declines in reported syphilis rates in eastern Europe and central Asia: are the epidemics over? Sex Transm Infect. 2000;76:363-365.
36. Rekart ML, Patrick DM, Chakraborty B, et al. Targeted mass treatment for syphilis with oral azithromycin. Lancet. 2003;361:313-314.
37. Bellis MA, Cook P, Clark P, Syed Q, Hoskins A. Re-emerging syphilis in gay men: a case-control study of behavioural risk factors and HIV status. J Epidemiol Community Health. 2002;56:235-236.
38. Wolf FC, Judson FN. Intensive screening for gonorrhea, syphilis, and hepatitis B in a gay bathhouse does not lower the prevalence infection. Sex Transm Dis. 1980;7:49-52.
39. Johnson WD, Hedges LV, Diaz RM. Interventions to modify sexual risk behaviors for preventing HIV infection in men who have sex with men. Cochrane Database Syst Rev. 2003(1):CD001230.
40. Morgan CA, Lukehart SA, Van Voorhis WC. Immunization with the N-terminal portion of Treponema pallidum repeat protein K attenuates syphilitic lesion development in the rabbit model. Infect Immun. 2002;70:6811-6816.
41. Blankenship KM, Bray SJ, Merson MH. Structural interventions in public health. AIDS. 2000;14 (suppl 1):S11-21.